Daniel J. Lovell, MD, MPH
Title
Associate Director, Division of Rheumatology
Appointment
Professor of Pediatrics
Email
daniel.lovell@cchmc.org
Phone
513-636-4676
Fax
513-636-5990
Credentials
MD: University of Kansas, Kansas City, Kan., 1978.
MPH: University of Texas School of Public Health, Houston, Texas, 1982.
Residency: Pediatrics, Children's Mercy Hospital, Kansas City, Kan.
Fellowship: Pediatric Rheumatology, Baylor College of Medicine, Houston, Texas.
Certification: Pediatrics, 1984; Pediatric Rheumatology, 1992.
Position History
Assistant Professor of Pediatrics, University of Cincinnati Medical School, 1984-1991
Associate Professor of Pediatrics, 1991 -2000
Professor of Pediatrics, University of Cincinnati Medical Center, 2000-Present
Awards and Honors
- Best Doctors in America, 2008
- Awarded "2005 Best Doctors"
- Earl Brewer Award, American Juvenile Arthritis Organization
- Elected to Society for Pediatric Research
- National Service Citation, Arthritis Foundation
- Pediatric Committee, Pan-American League against Rheumatism
- Elected to American Pediatric Society
- Joseph E. Levinson Endowed Chair in Pediatric Rheumatology
Research
Performance of clinical trials in children with rheumatic diseases; clinical trials methodology; mentoring of junior faculty
Research Grants and Contracts
P60 AR 44059 (Glass)
07/01/96 - 05/31/01
MAMDC--University of Cincinnati College of Medicine EEHSR Project (Lovell)"Randomized controlled trial of calcium supplementation for bone mineralization in JRA"
P60 AR 44059 (Glass) 07/01/96 - 05/31/01
MAMDC--University of Cincinnati College of Medicine, "Administrative Unit"
K24 AR 02154 (Lovell) 04/01/2000 - 03/31/2005
"Clinical trials in pediatric rheumatology"
R03 AI44046 (Lovell) 09/30/98 - 08/31/01
"Development and validation of core sets of outcome measures and definitions of improvement for juvenile dermatomyositis and juvenile systemic lupus erythematosus."
Immunex Corporation (Estimated Period) 04/01/00 - 03/31/05
The major goal of this project is to assess the longer-term (3-5 years) safety of Enbrel in polyarticular JRA patients.
P60 AR00-001 (Glass)
09/01/01- 08/31/06
Multidisciplinary Clinical Research Center in Cincinnati Project (Lovell) "Towards improved understanding of pathogenesis and treatment of childhood onset dermatomyositis."
P60 AR00-001 (Glass)
09/01/01- 08/31/06
Multidisciplinary Clinical Research Center in Cincinnati Administrative Core-Associate Director
Publications, Most Recent
Hermine I. Brunner, Daniel J. Lovell, Barbara K. Finck, Edward D. Giannini. Preliminary definitions of disease flare in juvenile rheumatoid arthritis (JRA).J Rheum 2002;29:1058-64.
Aksentijevich I, Nowak M, Mallah M, Chae JJ, Watford Wt, Hofmann SR, Stein L, Russo R, Goldsmith D, Dent P, Rosenberh HF, Austin F, Remmers EF, Balow JE, Rosenzweig S, Komarow H, Shoham NG, Wood G, Jones J, Mangra N, Carrero H, Adams BS, Moore TL, Schikler K, Hoffman H, Lovell DJ, Lipnick R, Barron K, O'Shea JJ, Kastner DL, Goldbach-Mansky R. De novo CIAS1 mutations, cytokine activation and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.Arthritis Rheum 2002;46:3340-8.
Lovell DJ, Giannini EH, Reiff A, Jones OY, Schneider R, Olson JC, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Lange M, Finck BK, Burge DJ for the Pediatric Rheumatology Collaborative Study Group. Long-term efficacy and safety of Etanercept in children with polyarticular-course Juvenile Rheumatoid Arthritis: Interim results from an ongoing multicenter, open-label, extended-treatment trial.Arthritis Rheum 2003;48:218-226.
Bowyer SL, Roettcher PA, Higgins GC, Adams B, Myers LK, Wallace C, Rennebohm R, Moore TL, Pepmueller PH, Spencer C, Wagner-Weiner L, Rabinovich E, Passo M, Lovell DJ, McCurdy D, Zemel L, Schikler KN, Szer I, Kurtin P, Lindsley C.. Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis. J Rheumatol 2003;30(2):394-400.
Murray KJ, Lovell DJ. Advanced therapy for juvenile arthritis.Best Pract Res Clin Rheumatol 2002; 16:361-78.
Brunner, HI, Jones OY, Lovell DJ, Johnson AM, Alexander P, Klein-Gitelman MS. Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage.Lupus 2003; 12:600-606.
Ruperto N, Ravelli A, Murray KJ, Lovell DJ, Andersson-Gare B, Feldman BM, Garay S, Kuis W, Machado C, Pachman L, Prieur AM, Rider LG, Silverman E, Tsitsami E, Woo P, Giannini EH, Martini A for the Paediatric Rheumatology International Trials Organization (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG). Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis.Rheumatology (Oxford) 2003; 42: 1452-9.
Brunner, HI, Klien-Gitelman MS, Miller MJ, Trombley M, Baldwin N, Kress A, Johnson AL, Barron AC, Griffin TA, Passo MH, Lovell DJ. Health of children with chronic arthritis: relationship of different measures and the quality of parent proxy reporting.Arthritis Rheum 2004; 51:763-73
Lovell DJ, Zaoutis TE, Sullivan K. Immunosuppressents, infection, and inflammation.Clin. Immunol. 2004; 113:137-9.
Andrea C. Barron, Tsz-Leung Lee, Janalee Taylor, Terry Moore, Murray H. Passo, T. Brent Graham, Thomas A. Griffin, Alexei A. Grom, Daniel J. Lovell and Hermine I. Brunner. Feasibility and construct validity of the parent willingness-to-pay technique for children with idiopathic arthritis.Arthritis Care and Research 2004; 899-908
Dan Lovell. Biologic agents for the treatment of juvenile rheumatoid arthritis. Pediatric Drugs 2004; 6: 137-146.
Hermine I. Brunner, Marisas. Klien-Gitelman, Michael J. Miller, Andrea Barron, Nicole Baldwin, Michael Trombley, Anne L. Johnson, Angie Kress, Daniel J. Lovell, Edward H. Giannini. Minimal clinically important differences of the Childhood Health Assessment Questionnaire.J Rheum 2005; 32:150-61
Editorial Positions
- Medical Advisory Board member, Lupus News, Newsletter of Lupus Foundation of America
- Editorial Board, Clinical and Experimental Rheumatology
- Editorial Board, Arthritis Care and Research
- Editorial Advisory Board, Current Rheumatology Reviews
Professional Organization Memberships
- American College of Rheumatology
- Pediatric Rheumatology Collaborative Study Group (Chairman)
- Childhood Arthritis and Rheumatology Research Alliance (Steering Committee Member)
- Pediatric Rheumatology International Clinical Trials Organization
- Pediatric Rheumatology European Society
Special Interests
Diagnostic evaluation and ongoing care of children with all pediatric onset rheumatic diseases
Related Areas
This person works in these other areas at Cincinnati Children's Hospital Medical
Center:
